Forward Citations = 99

Loading Chart...

4 inventors (with patents filed for the assignee):

David Wraith (8 out of 14 patents)

Heather Streeter (8 out of 8 patents)

Mary Ponsford (1 out of 1 patent)

4. Graziella Mazza (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 10377800 - Myelin oligodendrocyte glycoprotein (MOG) peptide (2019-08-13),

2. 9862751 - Myelin oligodendrocyte glycoprotein peptides (2018-01-09),

3. 9775880 - Methods of using myelin basis protein peptide compositions (2017-10-03),

4. 9381234 - Methods of using myelin basic protein peptide compositions (2016-07-05),

5. 8961986 - Peptide composition (2015-02-24),

6. 8623827 - Myelin basic protein peptide composition (2014-01-07),

7. 8343500 - Peptide composition (2013-01-01),

8. 7071297 - Tolerogenic peptides from myelin basic protein (2006-07-04),

Apitope is a biotech company located in Bristol, UK that specializes in the development of innovative antigen-specific immunotherapy treatments for autoimmune diseases. Their unique technology aims to reprogram the immune system to selectively target only harmful immune responses, offering a promising approach for treating conditions such as multiple sclerosis and Graves' disease.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

8 Patents

#2 in Chepstow

#2,048 in United Kingdom

Chepstow, United Kingdom

Apitope Technology (bristol) Limited

Forward Citations = 99

4 inventors:

David Wraith (8 out of 14 patents)

Heather Streeter (8 out of 8 patents)

Mary Ponsford (1 out of 1 patent)

4. Graziella Mazza (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com